These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27266285)

  • 21. Novel aspects of pathogenesis and regeneration mechanisms in COPD.
    Bagdonas E; Raudoniute J; Bruzauskaite I; Aldonyte R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():995-1013. PubMed ID: 26082624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood global DNA methylation is decreased in non-severe chronic obstructive pulmonary disease (COPD) patients.
    Zinellu A; Sotgiu E; Fois AG; Zinellu E; Sotgia S; Ena S; Mangoni AA; Carru C; Pirina P
    Pulm Pharmacol Ther; 2017 Oct; 46():11-15. PubMed ID: 28818709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD.
    Schwartz U; Llamazares Prada M; Pohl ST; Richter M; Tamas R; Schuler M; Keller C; Mijosek V; Muley T; Schneider MA; Quast K; Hey J; Heußel CP; Warth A; Winter H; Serçin Ö; Karmouty-Quintana H; Jyothula SS; Patel MK; Herth F; Koch I; Petrosino G; Titimeaua A; Mardin BR; Weichenhan D; Jurkowski TP; Imbusch CD; Brors B; Benes V; Jung B; Wyatt D; Stahl HF; Plass C; Jurkowska RZ
    EMBO J; 2023 Jun; 42(12):e111272. PubMed ID: 37143403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension.
    Luna RCP; de Oliveira Y; Lisboa JVC; Chaves TR; de Araújo TAM; de Sousa EE; Miranda Neto M; Pirola L; Braga VA; de Brito Alves JL
    Braz J Med Biol Res; 2018 Oct; 51(12):e7437. PubMed ID: 30365723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential of lipid-polymer nanoparticles as epigenetic and ROS control approaches for COPD.
    Chikuma K; Arima K; Asaba Y; Kubota R; Asayama S; Sato K; Kawakami H
    Free Radic Res; 2020 Dec; 54(11-12):829-840. PubMed ID: 31809610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-223 controls the expression of histone deacetylase 2: a novel axis in COPD.
    Leuenberger C; Schuoler C; Bye H; Mignan C; Rechsteiner T; Hillinger S; Opitz I; Marsland B; Faiz A; Hiemstra PS; Timens W; Camici GG; Kohler M; Huber LC; Brock M
    J Mol Med (Berl); 2016 Jun; 94(6):725-34. PubMed ID: 26864305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy.
    Lawless MW; O'Byrne KJ; Gray SG
    J Cell Mol Med; 2009 Sep; 13(9A):2800-21. PubMed ID: 19602054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From smoking to COPD--current approaches.
    Corlăţeanu A; Odajiu I; Botnaru V; Cemirtan S
    Pneumologia; 2016; 65(1):20-3. PubMed ID: 27209836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profile of epigenetic mechanisms in lung tumors of patients with underlying chronic respiratory conditions.
    Mateu-Jimenez M; Curull V; Rodríguez-Fuster A; Aguiló R; Sánchez-Font A; Pijuan L; Gea J; Barreiro E
    Clin Epigenetics; 2018; 10():7. PubMed ID: 29371906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic Targets for Therapeutic Approaches in COPD and Asthma. Nutrigenomics – Possible or Illusive.
    Cherneva RV; Kostadinov D
    Folia Med (Plovdiv); 2019 Sep; 61(3):358-369. PubMed ID: 32337921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise-modulated epigenetic markers and inflammatory response in COPD individuals: A pilot study.
    da Silva IRV; de Araujo CLP; Dorneles GP; Peres A; Bard AL; Reinaldo G; Teixeira PJZ; Lago PD; Elsner VR
    Respir Physiol Neurobiol; 2017 Aug; 242():89-95. PubMed ID: 28435027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung tumors, COPD and immune response: is epigenetics the bottom line?
    Balestro E; Baraldo S; Piloni D; Stella GM
    Minerva Med; 2016 Dec; 107(6 Suppl 1):1-8. PubMed ID: 28009152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives.
    Li CL; Liu SF
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic mechanisms in Parkinson's disease.
    Feng Y; Jankovic J; Wu YC
    J Neurol Sci; 2015 Feb; 349(1-2):3-9. PubMed ID: 25553963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quadriceps muscle weakness and atrophy are associated with a differential epigenetic profile in advanced COPD.
    Puig-Vilanova E; Martínez-Llorens J; Ausin P; Roca J; Gea J; Barreiro E
    Clin Sci (Lond); 2015 Jun; 128(12):905-21. PubMed ID: 25628226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease.
    Barnes PJ
    Proc Am Thorac Soc; 2009 Dec; 6(8):693-6. PubMed ID: 20008877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetics and environmental lung disease.
    Schwartz DA
    Proc Am Thorac Soc; 2010 May; 7(2):123-5. PubMed ID: 20427583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
    Wang J; Yu JT; Tan MS; Jiang T; Tan L
    Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are There Any Epigenetic Similarities Between Treatment Unresponsive Sarcoidosis, COPD and Severe Asthma?
    Mortaz E; Eslaminejad A; Varahram M; Heshmatnia J; Abedini A; Kiani A; Velayati A; Garssen J; Adcock IM
    Iran J Allergy Asthma Immunol; 2015 Oct; 14(5):472-5. PubMed ID: 26742435
    [No Abstract]   [Full Text] [Related]  

  • 40. Epigenetic regulation of airway inflammation.
    Adcock IM; Tsaprouni L; Bhavsar P; Ito K
    Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.